Financials

  • Market Capitalization N/A
  • Employee 704
  • Founded 1999
  • CEO Paul StoffelsPaul Stoffels
  • Website www.glpg.com
  • Headquarter Belgium
  • FIGI BBG000BJQY75
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
Price to sales ratio
Dividends per share
Dividend yield %

Galapagos NV - American Depositary Shares

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis.

뉴스